Pluristem Therapeutics to Present at the International Society for Stem Cell Research (ISSCR) 7th Annual Meeting
Business Wire
posted: 9 DAYS 1 HOUR AGOPrintShareText SizeAAAPluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Moran Meiron Ph.D., Research Director, has been invited to present at the International Society for Stem Cell Research (ISSCR) on the "Mechanism of Action of Placental Derived Adherent Cells for the Treatment of Chronic Limb Ischemia". This is the ISSCR 7th Annual Meeting and it will be held on July 8-11, 2009 at the Centre Convencions Internacional, Barcelona, Spain.
“We at Pluristem, are thrilled to be part of the prestigious ISSCR conference, where the finest of stem cell researchers present,” stated Zami Aberman, Chairman, President and CEO of Pluristem. “I believe that innovative research done at Pluristem on placental-derived adherent stromal cells will aid in casting light on the fascinating world of placental cells.” |
